The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes ...
Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo ...